Both in Pharmaceuticals
Moleculin Biotech vs GT Biopharma
Over the past year MBRX returned −96.8% and GTBP returned −67.1%; their daily moves had a correlation of -0.02.
MBRX −96.8% GTBP −67.1%Growth of $1, one year, split-adjusted
| Metric | MBRX | GTBP |
|---|---|---|
| Price | $8.32 | $5.13 |
| Market cap | $8.5M | $9.3M |
| Today | +5.32% | −3.57% |
| 1 month | −14.5% | −15.9% |
| 6 months | −83.2% | −46.4% |
| Year to date | −87.4% | −73.9% |
| 1 year | −96.3% | −67.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $7.3M | $5.0M |
| Dividend yield | — | — |
| Volatility (60d) | 850.8% | 958.2% |
| Short % of float | 0.7% | 24.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).